vs
Side-by-side financial comparison of MicroAlgo Inc. (MLGO) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
MicroAlgo Inc. is the larger business by last-quarter revenue ($26.3M vs $18.3M, roughly 1.4× ROCKWELL MEDICAL, INC.). On growth, ROCKWELL MEDICAL, INC. posted the faster year-over-year revenue change (-25.6% vs -35.5%).
MicroAlgo Inc. is a technology enterprise specializing in custom algorithm optimization solutions. It mainly serves clients across smart city management, industrial internet, and e-commerce sectors, helping enterprises improve operational efficiency, reduce operating costs, and optimize data processing performance for real business scenarios.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
MLGO vs RMTI — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.3M | $18.3M |
| Net Profit | — | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | — | -2.2% |
| Net Margin | — | -3.0% |
| Revenue YoY | -35.5% | -25.6% |
| Net Profit YoY | — | 26.7% |
| EPS (diluted) | — | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $18.3M | ||
| Q3 25 | — | $15.9M | ||
| Q2 25 | $26.3M | $16.1M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | $34.6M | $24.7M | ||
| Q3 24 | — | $28.3M | ||
| Q2 24 | $40.8M | $25.8M | ||
| Q1 24 | — | $22.7M |
| Q4 25 | — | $-554.0K | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-1.5M | ||
| Q4 24 | $4.2M | $-756.0K | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $343.0K | ||
| Q1 24 | — | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | 26.4% | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | -2.2% | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | — | -8.4% | ||
| Q1 25 | — | -7.2% | ||
| Q4 24 | 7.0% | -2.1% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | -5.8% |
| Q4 25 | — | -3.0% | ||
| Q3 25 | — | -11.0% | ||
| Q2 25 | — | -9.3% | ||
| Q1 25 | — | -8.0% | ||
| Q4 24 | 12.1% | -3.1% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | -7.6% |
| Q4 25 | — | $-0.01 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | $0.56 | $-0.02 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $319.4M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $317.6M | $37.0M |
| Total Assets | $330.8M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | $319.4M | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | $164.9M | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | $66.7M | $11.9M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | — | $37.0M | ||
| Q3 25 | — | $37.0M | ||
| Q2 25 | $317.6M | $30.4M | ||
| Q1 25 | — | $31.5M | ||
| Q4 24 | $144.9M | $32.6M | ||
| Q3 24 | — | $29.1M | ||
| Q2 24 | $76.0M | $23.5M | ||
| Q1 24 | — | $20.6M |
| Q4 25 | — | $57.1M | ||
| Q3 25 | — | $57.5M | ||
| Q2 25 | $330.8M | $52.6M | ||
| Q1 25 | — | $54.0M | ||
| Q4 24 | $176.3M | $59.2M | ||
| Q3 24 | — | $57.1M | ||
| Q2 24 | $107.6M | $53.0M | ||
| Q1 24 | — | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | — | $1.8M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | $4.8M | $865.0K | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | — | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | $4.8M | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | 13.8% | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | 0.0% | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | 0.0% | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.15× | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MLGO
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
